{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T12:16:24Z","timestamp":1778328984373,"version":"3.51.4"},"reference-count":10,"publisher":"BMJ","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1993,10,1]]},"DOI":"10.1136\/jnnp.56.10.1129","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T22:20:59Z","timestamp":1226355659000},"page":"1129-1132","source":"Crossref","is-referenced-by-count":26,"title":["Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase."],"prefix":"10.1136","volume":"56","author":[{"given":"T C","family":"Gibbs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Payan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E M","family":"Brett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Lindstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Holme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P T","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","article-title":"Tyrosinaemia and related disorders","volume-title":"The metabolic basis of inherited disease. VIth Edition","author":"Goldsmith, L.A.; Laberge, C.","year":"1989","unstructured":"Goldsmith LA, Laberge C. Tyrosinaemia and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. VIth Edition, New York: McGraw Hill, 1989."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0009-8981(74)90179-X","article-title":"A modified fluorimetric method for tyrosine determination in blood spotted on paper; a mass screening procedure for tyrosinaemia","volume":"57","author":"Grenier, A.; Laberge, C.","year":"1974","unstructured":"Grenier A, Laberge C. A modified fluorimetric method for tyrosine determination in blood spotted on paper; a mass screening procedure for tyrosinaemia. Clin Chim Acta 1974;57:71-5.","journal-title":"Clin Chim Acta"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0009-8981(82)90117-6","article-title":"Detection of succinylacetone and the use of its measurements in mass screening for hereditary tyrosinaemia","volume":"123","year":"1982","unstructured":"Greiner A, Lescault A, Laberge C, Gagne R, Mamer 0. Detection of succinylacetone and the use of its measurements in mass screening for hereditary tyrosinaemia. Clin Chim Acta 1982;123:93-9.","journal-title":"Clin Chim Acta"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0140-6736(92)92724-T","article-title":"Neonatal screen for hereditary tyrosinaemia type","volume":"340","author":"Holme, E.; Lindstedt, S.","year":"1992","unstructured":"Holme E, Lindstedt S. Neonatal screen for hereditary tyrosinaemia type I. Lancet 1992;340:850.","journal-title":"I. Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM199002153220704","article-title":"Neurologic crises in hereditary tyrosinemia","volume":"322","author":"Mitchell, G.; Larochelie, J.; Lambert, M.","year":"1990","unstructured":"Mitchell G, Larochelie J, Lambert M, et al. Neurologic crises in hereditary tyrosinemia. NEnglJIMed 1990;322: 432-7.","journal-title":"NEnglJIMed"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-3476(77)80701-4","article-title":"Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels","volume":"90","author":"Strife, C.F.; Zuroweste, E.L.; Emmett, E.A.","year":"1977","unstructured":"Strife CF, Zuroweste EL, Emmett EA, et al. Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels. J Pediatr 1977;90:400-4.","journal-title":"J Pediatr"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3476(05)81867-0","article-title":"Hematin therapy for the neurological crisis of tyrosinemia","volume":"118","author":"Rank, J.M.; Leone, A.P.; Payne, W.","year":"1991","unstructured":"Rank JM, Leone AP, Payne W, et al. Hematin therapy for the neurological crisis of tyrosinemia. J Pediatr 1991; 118:136-9.","journal-title":"J Pediatr"},{"key":"ref_8","first-page":"632","article-title":"Atassia acute in tirosinaemia tipo I. Nuovo aspetto di una rara malattia","volume":"17","author":"Burlina, A.; Bordugo, A.; Dussini, N.","year":"1991","unstructured":"Burlina A, Bordugo A, Dussini N, et al. Atassia acute in tirosinaemia tipo I. Nuovo aspetto di una rara malattia. Riv Ital Pediatr 1991;17:632-4.","journal-title":"Riv Ital Pediatr"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Linstedt, S.; Holme, E.; Lock, E.A.; Strandvik, B.","year":"1992","unstructured":"Linstedt S, Holme E, Lock EA, Strandvik B. Treatment of hereditary tyrosinaemia type I by inhibition of 4hydroxyphenylpyruvate dioxygenase. Lancet 1992;340: 813-7.","journal-title":"Lancet"},{"key":"ref_10","first-page":"797","article-title":"Clinical electromyography in infancy and childhood","author":"Payan, J.","year":"1990","unstructured":"Payan J. Clinical electromyography in infancy and childhood. In: Brett EM, ed. Paediatric neurology,. 2nd Edinburgh: Churchill Livingstone, 1990;797-829."}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.56.10.1129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:42:23Z","timestamp":1601088143000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.56.10.1129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,10,1]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1993,10,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.56.10.1129","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1993,10,1]]}}}